OncLive News Network®

August 9, 2017

August 2, 2017

July 26, 2017

July 12, 2017

July 5, 2017

June 28, 2017

June 22, 2017

June 14, 2017

ALK-Positive NSCLC: Better Agents as Frontline Therapy

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

June 7, 2017

May 31, 2017

May 24, 2017

The Evolving Landscape of Therapy for HR+ MBC

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

May 17, 2017

Mark A. Socinski, MD

May 10, 2017

May 3, 2017

April 26, 2017

The Changing Landscape: Therapy for Recurrent Ovarian Cancer

Ovarian Cancer

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Revolutionary Advances for Treating Urothelial Carcinoma

Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Immuno-Oncology

Biosimilars

Brain Cancer

HER2+ Breast Cancer

CAR T-cell Therapy

COVID-19

Colorectal Cancer

Gastrointestinal Cancer

Prostate Cancer

Urothelial Cancer

Gynecologic Oncology

Head & Neck Cancers

Chronic Lymphocytic Leukemia

Mantle Cell Lymphoma

Multiple Myeloma

Myeloproliferative Neoplasms

Non-Hodgkin Lymphoma

Hematologic Oncology

Melanoma & Skin Cancer

Oncology Business Management

Pediatric Oncology

Precision Medicine in Oncology®

Sarcomas

Supportive Care

Clinical